2025. What is The Comparative Effectiveness of Targeted Therapy versus Immunotherapy in Terms of Overall Survival, Progression-free Survival, and Quality of Life For Patients With Metastatic Renal Cell Carcinoma? : A Systematic Review and Meta-Analysis . Journal of Carcinogenesis. 24, 10s (Nov. 2025), 274–299. DOI:https://doi.org/10.64149/J.Carcinog.24.10s.274-299.